Draegerwerk Ag & Co. Kgaa · XETR:DRW8
Draegerwerk Ag & Co. Kgaa — Drägerwerk AG & Co. KGaA — FY2025 Earnings Presentation
20 slides from Draegerwerk Ag & Co. Kgaa's earnings presentation, Mar 24, 2026
Slide 1: Analyst Conference
Analyst Conference Drägerwerk AG & Co. KGaA March 24, 2026, Lübeck
Slide 2: Disclaimer
Disclaimer — This presentation does not constitute an offer of securities for sale or a solicitation of an offer to purchase any securities. No money, securities or other consideration is being solicited by this presentation. This presentation contains forward-looking statements regarding the future
Slide 3: Agenda
Agenda — 01 Dräger Business Highlights 02 Financials FY 2025 03 Outlook FY 2026 Drägerwerk AG & Co. KGaA 3
Slide 4: Dräger Business Highlights
01 Dräger Business Highlights Drägerwerk AG & Co. KGaA 4
Slide 5: 2025 Highlights
2025 Record net sales and Cash flow and margin significant increase in earnings considerably improved Highlights Highest net sales in the Company's history: net sales slightly above forecast; growth in both divisions Improved profitability: earnings and margin higher than and all regions Net sales E
Slide 6: Headwind compensated
Headwind compensated EBIT1 +20.3% 5.8% 6.7% EBIT margin EBIT margin 2024 2025 Tailwind 233 Headwind from positive one-off effects from 194 from negative currency the sale of non-strategic business and tariff effects activities and real estate ~EUR 22 million ~EUR 71 million 2024 2025 1 EBIT = Earnin
Slide 7: Corporate Objectives
Corporate EBIT margin1 Objectives 6.7% 5.8% +0.9% 4.9% +0.9% EBIT1 #1 Profitability first Group -2.9% 194 233 166 #2 Innovation Leadership -89 2023 2024 2025 #3 System Business and Recurring Business 2022 1 EBIT = Earnings before net interest result and income taxes Drägerwerk AG & Co. KGaA 7
Slide 8: Financials FY 2025
02 Financials FY 2025 Drägerwerk AG & Co. KGaA 8
Slide 9: Business development Group
Business development Group Order entry Q4 2025 FY 2025 — (change) (fx-adj.) (fx-adj.) Germany -1.3 -0.2 EMEA +4.5 +9.5 Net sales (€ million) Americas +12.4 +17.3 +5.3% APAC +1.5 +2.5 fx-adj 3,371 3,482 Total +4.3 +7.7 +3.3% nominal 780 833 1,138 • Order entry clearly above high prior-year figure due
Slide 10: Business development Medical
Business development Medical Order entry Q4 2025 FY 2025 — (change) (fx-adj.) (fx-adj.) Germany +1.4 +3.6 EMEA -1.1 +7.8 Net sales (€ million) Americas +15.3 +20.5 +7.4% APAC -6.7 +1.4 fx-adj +5.0% Total +2.2 +8.9 nominal 1,900 1,996 673 • Order entry significantly increased, driven by high demand f
Slide 11: Business development Safety
Business development Safety Order entry Q4 2025 FY 2025 — (change) (fx-adj.) (fx-adj.) Germany -4.5 -4.4 EMEA +11.0 +11.3 Net sales (€ million) Americas +7.3 +11.0 +2.6% APAC +17.6 +4.4 fx-adj +1.0% Total +7.2 +6.1 nominal 1,471 1,486 • Order entry clearly increased, particularly driven by engineere
Slide 12: Key figures
Key figures 2025 2024 Change € million € million % Cash flow (from operating activities) 238.3 167.3 +42.4 Investments 166.8 126.2 +32.2 Free cash flow 140.2 123.9 +13.1 Cash and cash equivalents1 282.1 230.6 +22.3 Net financial debt1 123.0 165.0 -25.4 Net financial debt1 / EBITDA2 0.3 0.5 Capital e
Slide 13: Earnings per share
Earnings per share1 Development since 2022 — 7.42 7.48 6.61 6.67 5.86 5.92 -3.47 -3.41 2023 2024 2025 2022 Common share Preferred share 1 in EUR Drägerwerk AG & Co. KGaA 13
Slide 14: Outlook FY 2026
03 Outlook FY 2026 Drägerwerk AG & Co. KGaA 14
Slide 15: Dividend proposal
Dividend proposal 2024 (in EUR million) 2025 (in EUR million) Net profit attributable to shareholders excl. minority interest 124.4 139.5 Dividend 37.5 42.0 • Common shares 20.0 22.5 • Preferred shares 17.5 19.5 Net payout ratio (in %) 30.1 30.1 Dividend per share 2024 (in EUR) 2025 (in EUR) • Commo
Slide 16: Outlook
Outlook Results achieved Forecast for for fiscal year 2025 fiscal year 2026 Net sales (net of currency effects) 5.3% 2.0 to 6.0% EBIT margin 6.7% 5.0 to 7.5% Dräger Value Added (DVA) EUR 90.1 million EUR 20 to 120 million Drägerwerk AG & Co. KGaA 16
Slide 17: Questions & Answers
Questions & Answers Drägerwerk AG & Co. KGaA 17
Slide 18: Financial calendar
Financial calendar Dräger publishes preliminary results approximately 2 weeks before the dates of the quarterly reports. Preliminary results for the full year are published in January. March 24, 2026 Annual Report 2025 Analysts‘ conference April 30, 2026 Report for the first three months 2026 Confer
Slide 19: Contact
Contact Visit our Investor Relations website: https://www.draeger.com/en-us_us/Investor-Relations Thomas Fischler | Head of Treasury & Investor Relations Moislinger Alle 53-55 23558 Lübeck, Germany Tel. +49 451 882 2685 Mail: thomas.fischler@draeger.com Nikolaus Hammerschmidt | Investor Relations Ma
Slide 20: Thank you
Thank you Drägerwerk AG & Co. KGaA 20
Drägerwerk AG & Co. KGaA — FY2025 Earnings Presentation on 6ix